摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1alpha-Phenyl-2beta-(hydroxymethyl)cyclopropanecarbonitrile | 910028-42-1

中文名称
——
中文别名
——
英文名称
1alpha-Phenyl-2beta-(hydroxymethyl)cyclopropanecarbonitrile
英文别名
(1R,2S)-2-(hydroxymethyl)-1-phenylcyclopropane-1-carbonitrile
1alpha-Phenyl-2beta-(hydroxymethyl)cyclopropanecarbonitrile化学式
CAS
910028-42-1
化学式
C11H11NO
mdl
——
分子量
173.214
InChiKey
YDIYUDSRGPPHKA-MNOVXSKESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    44
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1alpha-Phenyl-2beta-(hydroxymethyl)cyclopropanecarbonitrile盐酸氢氧化钾 、 sodium azide 、 lithium amide四溴化碳三苯基膦 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 生成 (1R,2S)-1-phenyl-2-(azidomethyl)-N,N-diethylcyclopropanecarboxamide
    参考文献:
    名称:
    (+)-和(-)-米那普仑及其构象受限的类似物的合成
    摘要:
    (R)-表氯醇[(R)-5 ]与苯乙腈(6)在NaNH 2的存在下在苯中的反应生成环丙烷衍生物,其被分离为内酯4 [(1 S,2 R)-2-氧-在氰基进行碱性水解后,96%ee的1-苯基-3-氧杂双环[3,1,0]己烷]的收率为67%。化合物4容易地转化为(+)-米那普仑[(+)- 1 ],由此证实了(+)- 1的绝对立体化学。(1 S,2 R)-1-苯基-2-[((S)-1-氨乙基]-环丙烷-N,N-diethylcarboxamindes(2),构象受限的1的类似物,还从4合成高对映体纯度。从(S)-表氯醇[(S)-5 ]开始,还合成了它们相应的对映异构体,即(-)-米那普仑[(-)- 1 ]和ent-2 。
    DOI:
    10.1016/0040-4039(95)02221-x
  • 作为产物:
    描述:
    (1S)-1-({[tert-butyl(dimethyl)silyl]oxy}methyl)-2-cyano-2-phenylethyl 4-methylbenzenesulfonate 在 四丁基氟化铵双(三甲基硅烷基)氨基钾 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 1.0h, 生成 1alpha-Phenyl-2beta-(hydroxymethyl)cyclopropanecarbonitrile
    参考文献:
    名称:
    Stereocontrolled Synthesis of Trisubstituted Cyclopropanes:  Expedient, Atom-Economical, Asymmetric Syntheses of (+)-Bicifadine and DOV21947
    摘要:
    An expedient, atom-economical, asymmetric synthesis of 1-aryl-3-azabicyclo[3.1.0]hexanes, including (+)-Bicifadine and DOV21947, in a single-stage through process without isolation of any intermediates has been developed. The key of this synthesis is the in-depth mechanistic understanding of the complicated epoxy nitrile coupling at each reaction stage. Therefore, the desired trisubstituted cyclopropane can be prepared in high ee and yield by controlling the reaction pathway through manipulating the nitrile anion aggregation state.
    DOI:
    10.1021/ol061650w
点击查看最新优质反应信息

文献信息

  • [EN] A NEW PROCESS FOR PREPARING OPTICALLY PURE MILNACIPRAN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS.<br/>[FR] NOUVEAU PROCÉDÉ DE PRÉPARATION DE MILNACIPRAN OPTIQUEMENT PUR ET DE SES SELS DE QUALITÉ PHARMACEUTIQUE
    申请人:ARCH PHARMALABS LTD
    公开号:WO2012059933A1
    公开(公告)日:2012-05-10
    The present invention relates to an improved and commercially, viable process for the resolution of racemic cis milnacipran of formula I and its pharmaceutically acceptable salts of formula II. The present invention comprises using racemic cis milnacipran or its pharmaceutically acceptable salts as starting material, a low cost and commercially available resolving agent of formula III and industrially safe and economically low cost material such as water as a solvent. The said process results into optical isomers of racemic cis milnacipran having excellent optical purity without involving multiple crystallization steps. The present invention also comprises the concept of green chemistry as the invention works well with water as a solvent thereby minimizing the use of any other solvent. (Formular I and II should be inserted here) Wherein X is anion selected from Cl, Br, I, HSO4, Phosphate or organic acid(Formular III should be inserted here) *represent asymmetric centre Compound of formula III represent mandelic acid and its derivatives.
    本发明涉及一种改进的商业可行的过程,用于分离式异构体顺式米纳西普兰(化学式I)及其药用可接受盐(化学式II)。本发明包括使用顺式米纳西普兰的异构体或其药用可接受盐作为起始物质,以及具有低成本且商业上可获得的分离剂(化学式III)和工业安全以及经济低成本材料(如水)作为溶剂。该过程导致顺式米纳西普兰的光学异构体具有优异的光学纯度,而无需进行多次结晶步骤。本发明还包括绿色化学概念,因为该发明与水作为溶剂良好配合,从而最小化了对任何其他溶剂的使用。 (化学式I和II应在此处插入) 其中X是从Cl、Br、I、HSO4、磷酸盐或有机酸中选择的阴离子 (化学式III应在此处插入) *代表不对称中心,化合物的化学式III代表苯乙酸及其衍生物。
  • PROCESS FOR PREPARING OPTICALLY PURE MILNACIPRAN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
    申请人:Pai Ganesh Gurpur
    公开号:US20120289744A1
    公开(公告)日:2012-11-15
    The present invention relates to an improved and commercially, viable process for the resolution of racemic cis milnacipran of formula I and its pharmaceutically acceptable salts of formula II. The present invention comprises using racemic cis milnacipran or its pharmaceutically acceptable salts as starting material, a low cost and commercially available resolving agent of formula III and industrially safe and economically low cost material such as water as a solvent. The said process results into optical isomers of racemic cis milnacipran having excellent optical purity without involving multiple crystallization steps. The present invention also comprises the concept of green chemistry as the invention works well with water as a solvent thereby minimizing the use of any other solvent. (Formular I and II should be inserted here) Wherein X is anion selected from Cl, Br, I, HSO 4 , Phosphate or organic acid (Formular III should be inserted here) *represent asymmetric centre Compound of formula III represent mandelic acid and its derivatives.
    本发明涉及一种改进的商业化可行的过程,用于分离式解决式I的顺式米纳西普兰的外消旋体和其药用可接受盐II。本发明包括使用外消旋式顺式米纳西普兰或其药用可接受盐作为起始物质,采用具有低成本和商业化可用性的分离剂III的工业安全和经济低成本材料,例如水作为溶剂。所述过程导致具有优异光学纯度的外消旋式顺式米纳西普兰的光学异构体,而无需进行多次结晶步骤。本发明还包括绿色化学的概念,因为该发明在水作为溶剂的情况下运作良好,从而最大限度地减少了对任何其他溶剂的使用。其中X是从Cl、Br、I、HSO4、磷酸盐或有机酸中选择的阴离子。III的化学式应插入此处,*代表不对称中心,化合物III的化学式代表苹果酸及其衍生物。
  • Synthesis and Characterization of Process Related Impurities of (±)-Milnacipran
    作者:P. Raja Gopal、A. Christy Prabakar、ERR Chandrashekar、B. Vijaya bhaskar、P. Veera Somaiah
    DOI:10.1002/jccs.201200484
    日期:2013.6
    Milnacipran is a cyclopropane derivative, used as an anti depressant drug. During the process development of milnacipran, four process related potential impurities were detected in high performance liquid chromatography. All these impurities were identified, synthesized and subsequently characterized by their respective spectral data (IR, LC‐MS, 1H NMR, and 13C NMR) as described in this article.
    米那普仑是一种环丙烷衍生物,用作抗抑郁药。在米那普仑的工艺开发过程中,高效液相色谱法检测到四种与工艺相关的潜在杂质。如本文所述,所有这些杂质均经过鉴定,合成并随后通过其各自的光谱数据(IR,LC-MS,1 H NMR和13 C NMR)进行了表征。
  • One-pot cyclization of dilithiated nitriles with isothiocyanates and epibromohydrin. Synthesis of 2-cyano-1-(hydroxymethyl)cyclopropanes and 2-cyanomethylidene-4-(hydroxymethyl)thiazolidines
    作者:Uwe Albrecht、Ilia Freifeld、Helmut Reinke、Peter Langer
    DOI:10.1016/j.tet.2006.03.072
    日期:2006.6
    The cyclization of dilithiated nitriles with epibromohydrin afforded 2-cyano-1-(hydroxymethyl)cyclopropanes. 2-Cyanomethylidene-(4-hydroxymethyl)thiazolidines were prepared by one-pot cyclization of dilithiated nitriles with isothiocyanates and epibromohydrin. (c) 2006 Elsevier Ltd. All rights reserved.
  • WO2007/127421
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐